For people living with Type 1 Diabetes, keeping blood sugar levels in check is a constant challenge. A new clinical trial at ...

Beta Bionics (BBNX) leads innovation in the diabetes treatment market with its groundbreaking iLet Bionic Pancreas technology ...

Medtronic and the US FDA shy away from calling the device an ‘artificial pancreas’ - patients still need to enter information about anticipated meals and instruct it to deliver bolus insulin ...

Over the past decade, the rising cost of insulin epitomized the broader systemic issue of higher healthcare out-of-pocket ...

Being the first artificial pancreas to be launched in the ... It is the world's first tubeless insulin delivery system. Closed loop systems - those that automatically administer extra insulin ...

But in cases of Type One diabetes, the pancreas's ability to function has been damaged and its insulin producing cells are unable to work. Artificial insulin takes its place, but scientists have ...

JMU scientists studied insulin-producing cells in fruit flies, finding that secretion is influenced by gut hormones, ...

Insulin pumps and CGMS provide greater flexibility, improved blood sugar control, and better quality of life for children and ...

[Tim] has diabetes and needs to monitor his blood glucose levels and administer insulin accordingly. As a first step, he and a community of other diabetics have been working on Android apps to log ...

All hybrid closed-loop systems improved time in range and time below range compared with other insulin therapies. MiniMed 780G achieved the greatest improvement in time in range of the systems.

The hormone adrenomedullin disrupts insulin signaling in blood vessel cells, contributing to systemic insulin resistance in obesity-associated type 2 diabetes, according to a new study.